Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders

Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders

US Patent 9365511 · Granted Jun 14, 2016

Estimated economic value: $3,778,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muscarinic acetylcholine M1 receptor antagonists2025
Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disor2025
Heterocycle substituted pyridine derivative antifungal agents2024
3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as2024
3-phenoxyazetidin-1-yl-heteroaryl pyrrolidine derivatives and the use thereof as2024
Cannabinoid receptor modulators2024
Muscarinic acetylcholine M1 receptor antagonists2024
Modulators of the beta-3 adrenergic receptor useful for the treatment or prevent2024
Substituted 3-phenoxyazetidin-1-yl-pyrazines2023
Substituted 3-phenoxyazetidin-1-yl-pyrazines2023
Pyridine derivatives substituted by heterocyclic ring and amino group2023
Cannabinoid receptor modulators2023